Page 137 - 《中国药房》2024年15期
P. 137

OU S Y,DU L,WEI J,et al. Effects of total flavone from   capsule against hepatic fibrosis based on network pharma‐
              Litchi  chinensis  Sonn.  on  rats  with  hepatic  fibrosis   cology[J]. Chin J Integr Tradit West Med Liver Dis,2023,
              through  JAK2/STAT3  signaling  pathway[J].  Lab  Med   33(6):518-524.
              Clin,2022,19(23):3216-3219.                    [31]  娄莹莹,李佃贵,周文平,等. 肝复健方对瘦素调控肝纤
          [23]  吴斌,王蓉,李胜男,等. 秦皮素通过调节JAK1/STAT3信                   维化大鼠 JAK2/STAT3 信号通路的影响[J]. 中医杂志,
              号通路抑制肝纤维化[J]. 中南药学,2019,17(3):420-425.              2013,54(9):781-784.
              WU  B,WANG  R,LI  S  N,et  al. Anti-fibrotic  effect  of   LOU Y Y,LI D G,ZHOU W P,et al. Effect of Ganfujian
              fraxetin  on  liver  fibrosis  in  rats  by  targeting  the  JAK1/  formula on the JAK2/STAT3 signaling pathway in leptin-
              STAT3 signaling pathway[J]. Cent South Pharm,2019,17  induced liver fibrosis in rats[J]. J Tradit Chin Med,2013,
              (3):420-425.                                        54(9):781-784.
          [24]  SALLAM A M,ESMAT A,ABDEL-NAIM A B. Cucur‐    [32]  贺松其,文彬,吕志平,等. 保肝宁对肝纤维化模型大鼠
              bitacin B attenuates CCl4-induced hepatic fibrosis in mice   肝组织形态学及 JAK2、STAT3 蛋白磷酸化水平的影响
              through  inhibition  of  STAT3[J].  Chem  Biol  Drug  Des,  [J]. 上海中医药杂志,2008,42(5):75-79.
              2018,91(4):933-941.                                 HE S Q,WEN B,LYU Z P,et al. Influence of “Bao Gan
          [25]  孟霞,王学丛,丰平,等. 瘦素对大鼠肝纤维化的信号转                        Ning” on liver histomorphology and protein phosphoryla‐
              导调控及槲寄生碱的干预作用[J]. 中国比较医学杂志,                         tion  levels  of  JAK2  and  STAT3  of  liver  fibrosis  rats[J].
              2015,25(10):1-6.                                    Shanghai J Tradit Chin Med,2008,42(5):75-79.
              MENG X,WANG X C,FENG P,et al. The signal trans‐  [33]  杨武斌,唐金凤,米本中. 柴胡疏肝散对早期肝纤维化大
              duction  pathway  of  rats  with  liver  fibrosis  regulated  by   鼠 JAK2/STAT3 信号通路的影响[J]. 癌变·畸变·突变,
              leptin and interfering effects of mistletoe alkali[J]. Chin J   2022,34(3):200-205.
              Comp Med,2015,25(10):1-6.                           YANG W B,TANG J F,MI B Z. Effects of Chaihushugan
          [26]  许湘,陆华冠,谢新,等. 二十五味松石丸调节巨噬细胞                        powder  on  the  JAK2/STAT3  signaling  pathway  in  rats
              表型改善 CCl4诱导的大鼠肝纤维化[J]. 中药药理与临                       with hepatic fibrosis[J]. Carcinog Teratog Mutagen,2022,
              床,2023,39(6):17-23.                                 34(3):200-205.
              XU X,LU H G,XIE X,et al. Ershiwuwei songshi pills   [34]  李晋,徐尚福,金凤,等 . 小柴胡汤下调 JAK2,STAT3 的
              improve CCl4 -induced liver fibrosis in rats by regulating   表达治疗大鼠肝纤维化[J]. 中国实验方剂学杂志,2014,
              macrophage  phenotype  [J].  Pharmacol  Clin  Chin  Mater   20(18):118-122.
              Med,2023,39(6):17-23.                               LI J,XU S F,JIN F,et al. Xiaochaihu tang depress expres‐
          [27]  李晋,姜妙娜,贾玉杰 . 肝复康对肝纤维化大鼠肝组织                        sion of JAK2 and STAT3 of liver fibrosis in rats[J]. Chin J
              JAK2 和 STAT3 表达的影响[J]. 临床肝胆病杂志,2010,                Exp Tradit Med Formulae,2014,20(18):118-122.
              26(5):527-530.                                 [35]  张学政,吴冬冰,张学娟,等. 黄芪建中汤对肝纤维化大
              LI J,JIANG M N,JIA Y J. Effect of Ganfukang on JAK2   鼠 JAK/STAT 信号通路的调节作用研究[J]. 中西医结合
              and STAT3 expression in rats with liver fibrosis[J]. J Clin   肝病杂志,2023,33(9):800-804,809.
              Hepatol,2010,26(5):527-530.                         ZHANG X Z,WU D B,ZHANG X J,et al. Regulatory ef‐
          [28]  王卫真,孟明辉,孔丽,等. Jak/Stat信号通路在经典CCl4                 fect of Huangqi jianzhong decoction on JAK/STAT signal
              大鼠肝纤维化模型中的动态变化及扶正化瘀方对其影                             pathway in rats with hepatic fibrosis[J]. Chin J Integr Tra‐
              响[J]. 临床肝胆病杂志,2014,30(4):344-348.                   dit West Med Liver Dis,2023,33(9):800-804,809.
              WANG W Z,MENG M H,KONG L,et al. Role of Jak/   [36]  厉姣龙,周振华. 柔肝方对肝纤维化小鼠肝脏内IL-22分
              Stat pathway in CCl4-induced rat liver fibrosis model and   泌和 IL-22R1 表达作用的研究[J]. 上海中医药大学学
              molecular action mechanism of Fuzheng huayu recipe in   报,2022,36(5):69-76.
              treatment of liver fibrosis[J]. J Clin Hepatol,2014,30(4):  LI J L,ZHOU Z H. Study on effects of Rougan formula
              344-348.                                            on  IL-22  secretion  and  IL-22R1  expression  in  liver  of
          [29]  林春凤,熊清,宁潇雨,等 . 基于网络药理学探讨 EGFR/                    mice  with  liver  fibrosis[J]. Acad  J  Shanghai  Univ Tradit
              JAK1/STAT3 通路在片仔癀抗肝纤维化中的作用[J]. 福                    Chin Med,2022,36(5):69-76.
              建中医药,2023,9(6):45-51.                          [37]  郑旭锐,李长秦,项颖环,等. 加味四逆散及拆方对肝星
              LIN C F,XIONG Q,NING X Y,et al. To explore the role   状细胞JAK2-STAT3信号通路的影响[J]. 辽宁中医药大
              of  EGFR/JAK1/STAT3  signaling  pathway  in  anti-hepatic   学学报,2012,14(3):67-69.
              fibrosis based on network pharmacology[J]. Fujian J Tra‐  ZHENG  X  R,LI  C  Q,XIANG Y  H,et  al.  Experiments
              dit Chin Med,2023,9(6):45-51.                       study  of  Jiawei  sinisan  and  the  separate  components  on
          [30]  倪沁雨,林佳成,涂天智,等. 基于网络药理学探讨克癀                        hepatic stellate cell of JAK2-STAT3 signal pathway[J]. J
              胶囊抗肝纤维化的作用机制[J]. 中西医结合肝病杂志,                         Liaoning Univ Tradit Chin Med,2012,14(3):67-69.
              2023,33(6):518-524.                                           (收稿日期:2023-12-02  修回日期:2024-03-25)
              NI Q Y,LIN J C,TU T Z,et al. The mechanism of Kehuang                               (编辑:唐晓莲)


          中国药房  2024年第35卷第15期                                              China Pharmacy  2024 Vol. 35  No. 15    · 1927 ·
   132   133   134   135   136   137   138   139   140   141   142